BioTech Nation ... with Dr. Moira Gunn
Science:Life Sciences
No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval.
Create your
podcast in
minutes
It is Free